Navigation Links
Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
Date:2/24/2009

SAN DIEGO, Feb. 24 /PRNewswire/ -- Ambrx Inc, and Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced a global strategic collaboration to develop and commercialize Ambrx's ARX424 preclinical product candidate for the treatment of multiple sclerosis. ARX424 was created by Ambrx through the application of its proprietary protein optimization technology, ReCODE(TM).

This second collaboration between the two companies follows a previous agreement announced in 2007 to develop ARX201, Ambrx's long-acting growth hormone product, currently in Phase II of clinical development.

Under the terms of the agreement, Merck Serono will receive worldwide exclusive development and commercialization rights for ARX424. Merck Serono will make an initial payment to Ambrx, and Ambrx is eligible to receive undisclosed clinical, regulatory and commercial milestone payments based upon the successful development and commercialization of potential products resulting from this collaboration, as well as undisclosed royalties on the associated worldwide net sales. Ambrx also retains the option to convert its right to receive royalties in the U.S. to a profit and loss sharing option. If the option is exercised, Ambrx and Merck Serono will share global development expenses, US commercialization expenses as well as profit. In addition, Merck Serono will make an undisclosed equity investment in Ambrx. Additional terms of the collaboration were not disclosed.

"This second collaboration with Ambrx not only demonstrates their robust research and development capability, it also strengthens our partnership to deliver innovative products to the market to help improve the quality of life of patients," said Vincent Aurentz, Executive Vice President Portfolio Development at Merck Serono.

"We are pleased to expand our productive relationship with Merck Serono, a company ideally suited to harness the potential of
'/>"/>

SOURCE Ambrx Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
2. Merck/Gilead Once-A-Day AIDS Pill Not Available in Most Places - AHF Urges Speed-Up of Registrations
3. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
4. MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
5. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
6. Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.
7. Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch
8. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
9. MicroDose Technologies Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under Collaboration with Merck & Co., Inc.
10. Diakron Licenses Anticoagulant Drug Candidate from Merck & Co., Inc.
11. Merck Serono Completes Enrollment in the REFLEX Trial of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Calif. , Nov. 26, 2014  Avanir ... that the U.S. Food and Drug Administration (FDA) ... New Drug Application (NDA) for AVP-825. AVP-825 is ... sumatriptan powder delivered intranasally utilizing a novel Breath ... Complete Response letter, and consistent with the preliminary ...
(Date:11/26/2014)... 2014  BioScrip ® , Inc. (NASDAQ: BIOS ) ... Executive Officer, will present at the Bank of America Merrill Lynch ... , Date: , , , Wednesday, December 3, 2014 , ... , , , Location: , , , Boca Raton Resort ... Inc. BioScrip, Inc. is a leading national ...
(Date:11/26/2014)... JOSE, Calif. , Nov. 26, 2014 /PRNewswire/ ... technologies to produce novel therapies for infectious diseases, ... , M.D., an internationally recognized key opinion leader ... the Company,s scientific advisory board. Founder ... Ph.D., stated, "We believe Dr. Opal,s extensive experience ...
Breaking Medicine Technology:Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3
... MALVERN, Pa., Nov. 17, 2010 Siemens ... System is now commercially available in the United ... diagnostic mammography, stereotactic biopsy, and upgrade capability to ... (Logo: http://photos.prnewswire.com/prnh/20070904/SIEMENSLOGO ) ...
... The National Community Pharmacists Association (NCPA) ... to unite to host what the organizers are calling ... the eastern Suffolk area of New York. ... ) According to event organizer and NCPA ...
Cached Medicine Technology:Siemens MAMMOMAT Inspiration Digital Mammography Commercially Available in U.S. 2Siemens MAMMOMAT Inspiration Digital Mammography Commercially Available in U.S. 3NCPA Commends Prescription Drug Take Back Event Hosted by 15 New York Pharmacies 2NCPA Commends Prescription Drug Take Back Event Hosted by 15 New York Pharmacies 3
(Date:11/28/2014)... An inventor and dental assistant from Kent, Wash., ... and it was almost impossible to reach. "This gave me ... , The patent-pending Access Light allows for easier use of ... the mouth, as well as avoids harm to the lips, ... use and clean, it also helps prevent cross-contamination. , The ...
(Date:11/28/2014)... York (PRWEB) November 28, 2014 ... ) have now been filed in a New ... metal implants, Bernstein Liebhard LLP reports. , ... Bergen County Superior Court reflects the filing of ... modular-neck hip stems, which were voluntarily recalled on ...
(Date:11/28/2014)... Lice Troopers Lice Removal Service is pleased to announce ... service for moms in Miami-Dade County. Lice Troopers is opening ... Pone De-leon Blvd in Miami. The company currently has ... & Broward. Lice Troopers is the only Lice Clinic that ... treating families for several years. , Lice Troopers estimate they ...
(Date:11/28/2014)... An inventor from Flint, Mich., wants to ... got this idea while lying in a hospital bed, unable ... , The Bed Buddy provides a more ergonomic and convenient ... It eliminates the need to leave the bed, which avoids ... Easy to use and producible in design variations, it's ideal ...
(Date:11/28/2014)... TN (PRWEB) November 28, 2014 ARTAS ... Tennessee for the first time. PAI Medical Group hair ... will be performing a robotic hair transplant procedure in ... 9:00 A.M. , The first in Tennessee and one ... Medical Group now offers ARTAS robotic hair transplantation. Patients ...
Breaking Medicine News(10 mins):Health News:More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports 2Health News:More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports 3Health News:Lice Troopers Lice Removal Service Expands in Miami-Dade 2Health News:First in Tennessee - PAI Medical Group Announces ARTAS - The World’s Most Advanced Medical Robot Used for Hair Transplant Surgery 2
... New research shows people who have used amphetamines ... an increased risk of developing Parkinson,s disease, according to ... the American Academy of Neurology,s 63rd Annual Meeting in ... Benzedrine and Dexedrine are amphetamines often prescribed to increase ...
... convergence of people, animals, and our environment has created ... group is inextricably and globally interconnected, without borders. It ... as a multidisciplinary effort to attain optimal health of ... focus of a session at the annual meeting of ...
... span becomes longer, dementia becomes more common. Swedish scientist Laura ... risk of being affected. Factors from blood pressure and weight ... cognitive functioning as one gets older. The lengthening of ... increase in the prevalence of aging related disorders, one of ...
... desire for smaller families for the decline in fertility rates ... unwanted births may actually be a larger factor. The ... people have better control of when and if they have ... Research at Ohio State University. "While it is true ...
... , This release is available in French ... water-related diseases continues to spread in cities around the world. ... the connection between cities, water and health at the THINK ... of Science (AAAS) conference Sunday. Mulligan is a PhD ...
... replacement surgery takes far more time to conduct in ... according to recent research at Hospital for Special Surgery ... the American Academy of Orthopaedic Surgeons annual meeting, held ... implications for hospital staff scheduling surgeries, operating room utilization ...
Cached Medicine News:Health News:Using amphetamines may increase risk of Parkinson's disease 2Health News:One Health: From ideas to implementation, rhetoric to reality 2Health News:One Health: From ideas to implementation, rhetoric to reality 3Health News:One Health: From ideas to implementation, rhetoric to reality 4Health News:Look after your brain 2Health News:Family planning programs have success in developing countries, but need to be expanded 2Health News:Family planning programs have success in developing countries, but need to be expanded 3Health News:Is the link between poverty and water-related disease making rich people sick? 2Health News:Knee replacement surgeries take more time, are more costly in overweight individuals 2Health News:Knee replacement surgeries take more time, are more costly in overweight individuals 3
Used for stenting the urethra after hypospadias or epispadias repair and to provide post-operative drainage of the bladder. Supplied sterile in peel-open packages. Intended for one-time use....
... for temporary internal drainage ... to the bladder. Supplied ... Intended for one-time use. ... advised; C-Flex® and Sof-Flex® ...
Used to introduce Cook-Cope loop and other catheters for percutaneous nephrostomy. Supplied sterile in peel-open packages. Intended for one-time use....
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: